about
Mechanism of association between BMI and dysfunction of the gastro-oesophageal barrier in patients with normal endoscopy.A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects.HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation.Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic RemissionDynamics of Colon Monocyte and Macrophage Activation During ColitisLetter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' replyImplementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World OutcomesReal-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortAssociation Between Level of Fecal Calprotectin and Progression of Crohn's DiseaseIBD prevalence in Lothian, Scotland, derived by capture-recapture methodologyBritish Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemicFaecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn's Disease: Correlations Between Disease Activity and Long-Term Follow-Up
P50
Q33451681-9D61D7D3-7E49-43A3-B89D-89096A85A907Q35549617-7CDBED84-6EA5-4D63-99B1-36C876A1D922Q38204995-A6CAC4E1-C11B-4E5F-87BB-E201923C4571Q42704205-0484F9CA-852F-4CDD-A966-3BB731AF3F2BQ52617363-BFF9C7C5-04A4-4848-9C02-74307D059F61Q58543806-E7476CA9-154B-4683-B487-4A78D91B850CQ59806949-D74B4101-956A-4C2C-AA11-08D9BB1240A3Q87415060-0D8894A1-11F6-45C2-A27F-1EA3D2AFD7CEQ90395376-BFA1E896-F480-413F-AE54-9FB638AEEA14Q91615683-0EF19F2D-E2F5-4A5A-8147-F7D771B51333Q91650453-F9E885A2-F659-4361-A0BC-E87D343235F8Q91839437-12092DFE-74DA-44AF-BB66-69C235CB1B54Q92024695-8201CAE2-58B7-4F75-AE96-31FE6E3FDE7BQ93211539-9485B4DD-7506-49F0-B69F-DCF19E9FC5F4
P50
description
researcher ORCID ID = 0000-0001-7355-2357
@en
wetenschapper
@nl
name
Gareth-Rhys Jones
@ast
Gareth-Rhys Jones
@en
Gareth-Rhys Jones
@es
Gareth-Rhys Jones
@nl
type
label
Gareth-Rhys Jones
@ast
Gareth-Rhys Jones
@en
Gareth-Rhys Jones
@es
Gareth-Rhys Jones
@nl
prefLabel
Gareth-Rhys Jones
@ast
Gareth-Rhys Jones
@en
Gareth-Rhys Jones
@es
Gareth-Rhys Jones
@nl
P108
P21
P31
P496
0000-0001-7355-2357